PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ADAM17 SUBSTRATE DEPENDANT CANCERS

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP16700033.0

公开号：

EP3237009A1

申请日:

2016.01.04

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

The present disclosure relates to the treatment of cancers and, more particularly, to the treatment of ADAM17 substrate dependant cancers which are refractory. The pharmaceutical composition contains an ADAM17 antibody (it recognizes an epitope within the membrane proximal domain of ADAM17 localized between the residues 564 and 642) characterized by the sequences of its variable chains.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/